HOLLENCREST CAPITAL MANAGEMENT - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 35 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
HOLLENCREST CAPITAL MANAGEMENT ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$45,150
-5.9%
129,0000.0%0.01%0.0%
Q3 2022$48,000
-18.6%
129,0000.0%0.01%
-14.3%
Q2 2022$59,000
-10.6%
129,000
-1.5%
0.01%
+16.7%
Q1 2022$66,000
-21.4%
131,000
-10.3%
0.01%
-14.3%
Q4 2021$84,000
-42.1%
146,000
+3.5%
0.01%
-46.2%
Q3 2021$145,000
-14.2%
141,0000.0%0.01%
-13.3%
Q2 2021$169,000
-7.7%
141,0000.0%0.02%
-11.8%
Q1 2021$183,000
-44.7%
141,000
+56.7%
0.02%
-51.4%
Q4 2020$331,000
+72.4%
90,0000.0%0.04%
+52.2%
Q3 2020$192,000
+392.3%
90,000
+317.2%
0.02%
+360.0%
Q2 2020$39,000
+39.3%
21,5710.0%0.01%
+25.0%
Q1 2020$28,000
-28.2%
21,5710.0%0.00%0.0%
Q4 2019$39,000
-66.7%
21,571
-46.5%
0.00%
-71.4%
Q3 2019$117,000
+8.3%
40,3210.0%0.01%
+7.7%
Q2 2019$108,000
+96.4%
40,321
+86.9%
0.01%
+85.7%
Q1 2019$55,0000.0%21,5710.0%0.01%0.0%
Q4 2018$55,0000.0%21,5710.0%0.01%0.0%
Q3 2018$55,00021,5710.01%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 56,250$206,0000.12%
Baker Brothers Advisors 4,608,786$16,914,0000.06%
Artal Group S.A. 500,000$1,835,0000.04%
HOLLENCREST CAPITAL MANAGEMENT 90,000$331,0000.04%
Spotlight Asset Group, Inc. 21,500$79,0000.03%
DCF Advisers, LLC 18,755$69,0000.03%
683 Capital Management, LLC 88,470$325,0000.02%
Palo Alto Investors LP 77,044$283,0000.02%
Alpine Global Management, LLC 13,966$51,0000.01%
TCI Wealth Advisors, Inc. 4,000$15,0000.01%
View complete list of IDERA PHARMACEUTICALS INC shareholders